Medicover's nomination committee for the AGM 2025
Medicover AB (publ) ("Medicover") publishes the nomination committee's composition for the annual general meeting ("AGM") in 2025.
- Fredrik Stenmo, representing Celox Holding AB and the Christina af Jochnick family's total shareholding
- Hans Ramel, NG Invest Beta AB
- Jannis Kitsakis, Fjärde AP-Fonden
- Sophie Larsén, AMF och AMF Fonder
The Board of Medicover AB (publ)
For more information, please visit: medicover.com (https://www.medicover.com/financial-information/corporate-governance/nomination-committee)
Shareholders who wish to submit proposals to the nomination committee for the AGM to be held on 29 April 2025 can do so by e-mail to nominationcommittee@medicover.com (nominationcommittee@medicover.com?subject=Proposals%20to%20the%20nomination%20committee%20for%20the%20AGM%202025)or:
Medicover AB
Attn: Nomination Committee/General Legal Counsel
Box 5283, 102 46 Stockholm, Sweden
Proposals should be submitted to the nomination committee no later than 11 March 2025.
For further information, please contact:
Hanna Bjellquist, Head of Investor Relations
+46 703 033 272
hanna.bjellquist@medicover.com
Medicover is a leading international healthcare and diagnostic services company and was founded in 1995. Medicover operates a large number of ambulatory clinics, hospitals, specialty-care facilities, laboratories and blood-drawing points and the largest markets are Poland, Germany, Romania and India. In 2023, Medicover had revenue of €1,746 million and more than 45,000 employees. For more information, go to www.medicover.com